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and intricate cellular system. In order to better understand the organization of proteins within the purinosome, we probed protein-protein interactions, or the proximity between protein pairs within the purinosome.
PPIs are known to be highly dependent on their cellular context. Specific protein modifications or structural alterations may also be required for certain interactions to occur (9, 10) so that their detection in vitro or in cell lysates might be difficult or impossible due to the absence of accessory proteins or other necessary cellular components. In order for a cellular PPI to induce a detectable reporter signal, the protein pairs under study often need to be engineered. In live cell FRET experiments, fluorescent proteins are fused with the protein of interest to create donor/receptor FRET pairs. However, the location of labeling relative to the PPI domain will affect the intensity of the FRET signal and might abnegate the detection of a cellular PPI. Similar issues also exist for protein complementation assays, in which two half molecules are brought together by a PPI to provide a detectable signal.
Here, we employed a previously reported "Tango Assay" system, and extended its usage from cell membrane proteins to cytosolic proteins. The assay revealed a landscape of features for the purinosome PPI network. It also provided insights into the mechanism of purinosome formation and pathophysiological conditions that might affect its function.
EXPERIMENTAL PROCEDURES:
Materials-We obtained b-arrestin2-TEV and arginine vasopressin receptor2-TEV cleavage sitetTA plasmids as a generous gift from Dr. Barnea (2) . The TEV cleavage site-tTA and TEV regions were sub-cloned into a pEGFP-N1 vector, replacing EGFP. Proteins in the de novo purine biosynthetic pathway were, individually, subcloned and inserted at the N-terminus of the TEV cleavage site-tTA or the TEV region. See SI text for details of plasmid construction. The highfidelity DNA polymerase, Pfu polymerase (Life Technologies), was used in generating the constructs. All constructs were verified by sequencing.
Cell culture-A human cervical cancer cell line, HeLa (ATCC), was maintained as described previously (1). Briefly, HeLa cells were cultured in either "purine-rich medium", MEM (Mediatech) supplemented with 10% FBS, or "purine-depleted medium", RPMI 1640 (Mediatech) supplemented with 5% dialyzed FBS. The antibiotic, gentamicin sulfate (Sigma), was used in the maintenance of the culture, but not included when batches of cells were transfected for the luciferase assay.
Transfection-HeLa cells suspended in "purine-rich medium" or "purine-depleted medium" without antibiotic were inoculated into 24-well cell culture plate at 30,000 or 40,000 cells per well densities. The following day, the cells were transfected with the XtremeGene transfection reagent (Roche), according to their protocol. Briefly, 100 µL cell culture medium containing no serum was mixed with plasmids and XtremeGene reagent and incubated at room temperature for 15 minutes before being added into a well on the 24-well cell culture plate. For each well, 100 ng of the TRE-TIGHT firefly luciferase construct, 100 ng of the TEV cleavage site-tTA fusion construct and 100 ng of either the TEV only construct or the TEV fusion construct, and 3 µL XtremeGene reagent were used. When measuring the luciferase signal induced by the tTA fusion protein in the absence of the TEV or the TEV fusion protein, 100 ng of the pEGFP-N1 plasmid was used in place of the TEV or the TEV fusion plasmids. When measuring normalized luciferase expression, an additional 10 ng of the renillar luciferase expression plasmid (Promega) was added to each well. After adding the transfection reagent, the plate was returned to the cell culture incubator and incubated for 2 hours before being rinsed and replaced with fresh medium. The plates of transfected cells were then incubated for two days before being used for the luciferase assay.
Luciferase Reporter Assay-Cells were harvested and luciferase expression was measured with a luciferase assay kit (Biotium), according to their protocol. Briefly, after removing the cell culture media, cells in 24-well plates were rinsed with PBS and kept on ice. 100 µL cell lysis buffer was added to each well. The plates, on ice, were placed on a rocking platform with gentle rocking for 15 minutes before beginning the luciferase assay. 100 µL of luciferase assay buffer was mixed with 20 µL cell lysate from each well, and the luminescence was measured on a Lumat LB 9501 luminometer (Berthold).
RESULTS:
Adapting the Tango Assay for Purinosome Proteins-A previously reported study used TEV and its cleavage of a specific peptide sequence to release a transcription factor that initiated expression of a reporter luciferase gene to capture protein proximity in cells (2) . We employed a similar strategy to test for PPI with cytosolic purinosome proteins. As shown in Figure 1A , first a fusion construct was made with the transcription factor, tTA (11) , linked to the C-terminus of a bait protein, with the optimized seven amino acid TEV cleavage site (tevS) for the highly specific TEV protease (2) interposed between them. A second fusion protein was constructed with the TEV protease linked to the C-terminus of a prey protein. The tTA-dependent inducible firefly luciferase expression vector was constructed by placing the firefly luciferase gene under TRE-TIGHT, a tTA-dependent promoter. When the three types of constructs are transiently introduced into cells, the PPI between the bait and prey fusion proteins will bring the fusion proteins into proximity so that the TEV protease can bind and cleave the linker peptide. Once tTA is released from the fusion protein, it is trafficked to the nucleus, where it can bind to the tTA-dependent promoter and initiate the transcription of firefly luciferase gene expression ( Figure 1B) . The luciferase assay then reports the presence of a PPI.
Crystallographic evidence indicated that most of the purine biosynthetic proteins are likely to have higher order quaternary structures. The structural data showed that hPPAT and hASL are tetrameric; hTrifGART and hATIC are dimeric, hPAICS is octameric; and only hFGAMS is monomeric (12) . It follows that, in vivo, PPIs should also be observed for individual proteins as they oligomerize. At the same time, the dynamic formation of the purinosome complex could bring the various purine biosynthetic proteins into proximity.
To test for PPIs, we first inserted the same purine biosynthetic enzyme into either the tTA or TEV fusion construct to serve as both bait and prey proteins for testing in the luciferase assay. As a control experiment, a TEV only construct was co-expressed with the tTA fusion protein to assess the probability of cleavage of the TEV substrate in the absence of a PPI. We saw an increase of the luciferase signal for all six proteins in the de novo purine synthetic pathway, as compared with the control experiment, and thus confirmed that all the fusion proteins function as expected. This increase in the luciferase reporter gene signal is a consequence of the subunit proximity resulting from their oligomerization to form a native protein in the cell. In the case of FGAMS, it must be due to purinosome formation. The diffusive TEV control did not efficiently bind to its target sequence in the tTA fusion protein ( Figure 1C ). We also observed these different tTA fusion proteins gave different background luciferase signals in the absence of the TEV fusion protein that may reflect the efficiency of different bait proteins tagged with tTA to retain tTA within the cytosol ( Figure S1 ). Generally, the tTA fusion proteins made with larger bait proteins, such as hFGAMS and hTrifGART, gave a lower background signal than others. Protein oligomerization or complex formation may also increase the retention of the tTA fusion protein in cytosol, leading to a relatively low background in the absence of TEV protein.
PPIs between hFGAMS, hTrifGART and
Other Purinosome Proteins-hFGAMS and hTrifGART are the largest two proteins in the de novo purine biosynthetic pathway (Molecular weight = 145 kDa and 108 kDa respectively). These proteins showed the highest frequencies of clustering and colocalization in purinosome images (2) . Based on its structure and the colocalization data, hFGAMS was proposed to provide a scaffold for purinosome formation (12) . In the initial experiments ( Figure 1C) , the tTA fusion protein of hFGAMS and hTrifGART gave a relatively low self background, which helped to detect an increase of the signal induced by a PPI with other proteins. We first tested for a PPI between hFGAMS, and the other purinosome proteins, with tTA attached to hFGAMS as bait and the other purine biosynthetic proteins tagged with TEV as prey. The results showed an increased signal (evidence of a PPI) with four purine synthetic enzymes, hPPAT, hPAICS, hASL and hATIC, but not with hTrifGART ( Figure 2A) . The PPI luciferase assay with hTrifGART and the other purine synthetic proteins as prey showed an increased signal with the last three proteins in the pathway, hPAICS, hASL and hATIC, but not with hFGAMS or hPPAT ( Figure 2B ). These data provide further support for the proposal that the purine biosynthetic proteins form an interacting complex, albeit possibly quite transient in nature, with hFGAMS and hTrifGART forming a core structure with which the others interact. Surprisingly, we did not detect an increase in the luciferase signal between hFGAMS and hTrifGART. Note that, in all cases, the signal strength was greater for purine minus versus the purine plus media consistent with greater purinosome formation under the former condition.
Since production of the luciferase signal could be affected by many factors including the protein-protein orientation as well as the interaction life time, an increase in luciferase signal relative to the control always is an indication of protein-protein proximity whereas the absence of a signal increase does not rule out the possibility of PPI between the protein pair tested. Consequently, given the sizes of the hFGAMS and hTrifGART fusion proteins, their orientation might not favor the TEV cleavage reaction. We tested for that possibility by truncating or generating individual domains of hTrifGART besides creating the hTrifGART fusions.
PPI between hFGAMS and hTrifGART DomainS-hTrifGART is a trifunctional protein, catalyzing steps 2, 3, and 5 in the purine biosynthetic pathway. The three functional domains on hTrifGART are, from the N-to Cterminus, GARS, AIRS, and GARTf. hTrifGART also has an additional, shorter isoform, stGART, formed by RNA alternative splicing (13) . In order to determine if the absence of the PPI signal between hFGAMS/hTrifGART was caused by the protein orientation of the full length hTrifGART protein, we tagged TEV protease to the C-terminus of the individual domains, the short isoforms, and also to the N-terminally or C-terminally truncated proteins, and tested their interaction with the hFGAMS-tTA fusion protein (Figure3A). These TEV fusion prey constructs were individually coexpressed to challenge the tTA fusion construct containing hFGAMS as the bait. The results of the luciferase assay showed the largest increase of luciferase signal when the AIRS domain was used as the prey. Fusing of the GARS domain to the Nterminal of TEV also increased the luciferase signal whereas the GARTf domain did not interact with FGAMS ( Figure 3B ). The N-terminal and Cterminal truncated forms of hTrifGART also interacted with hFGAMS and induced an increase in the luciferase signal. These data suggest that hFGAMS and hTrifGART do interact with each other, however in an orientation that prevents the TEV from accessing the tevS substrate. In short, testing with individual hTrifGART domains as well as truncated forms yielded a significant increase in the luciferase signal, thus implicating the proximity, of the two proteins in the cell.
PPIs between hPPAT, hPAICS, hASL, hATIC and Other Purinosome Proteins-In probing the proximity between hFGAMS and other purinosome proteins, we noticed that hPPAT, hPAICS, hASL and hATIC induced a large increase in the luciferase signal. With hTrifGART as the bait protein, we found that neither the hFGAMS-TEV nor hPPAT-TEV constructs gave a significant increase in the luciferase signal whereas the other enzymes did ( Figure 2B ). Given this pattern and their nearly contiguous activities, the two enzymes may be closely associated and as a prey complex unable to access the linker in the hTrifGART-tevS-tTA fusion protein. To further test this, we created a bait hPPAT fusion by tagging the C-terminus of hPPAT with tevS-tTA and with the TEV fusion purinosome enzymes as prey. The pattern ( Figure 2C ) was very similar to that with hFGAMS-tevS-tTA fusion protein (Figure 2A) , i.e., we observed similar increases in signal with hFGAMS, hPAICS, hASL, and hATIC, but not with the hTrifGART fusion protein. Considering these collective data, the two proteins either present a similar spatial configuration or are actually associated in the cell's cytosol. Since hFGAMS is monomeric whereas hPPAT is tetrameric, we favor the latter interpretation.
Next, we used hTrifGART isoforms, domains and truncated forms as prey proteins against the hPPAT fusion protein. We detected a nearly identical signal pattern as seen with the hFGAMS when AIRS, GARS, the short isoform of hTrifGART and truncated forms of hTrifGART were used as prey whereas no signal was seen with the hTrifGART (Figure 3C ). These results support the above interpretation. Since prey constructs of hPAICS, hASL and hATIC also induced significant increases with bait constructs of hFGAMS or hPPAT, we inserted them, individually, into the bait construct and tested with prey constructs containing other de novo purine biosynthetic proteins. The results turned out to be quite different from those with hFGAMS, hTrifGART or hPPAT bait construct ( Figure 4A , B, C). First, the bait constructs by themselves induced a relatively high luciferase signal in the absence of TEV or the TEV fusion construct ( Figure S1 ), suggesting that the tTA fusion protein had lower retention in the cytosol. Furthermore, TEV fusion proteins with hFGAMS, hPPAT, or hTrifGART as prey did not induce an increase in the magnitude of the luciferase signal to the extent seen when the bait was hFGAMS, hPPAT, or hTrifGART and one of the hPAICS, hASL, or hATIC proteins was the prey. This result probably arises from the asymmetry of the prey and bait complexes so that the complexation contacts between bait/prey proteins when the two are switched cannot be the same.
DISCUSSION:
Purine de novo biosynthetic enzymes were long proposed to form a cellular complex, which has only recently been observed using fluorescent microscopy and we now term the purinosome (1). Despite its discovery, it was unclear how the enzymes were trafficked to a particular location in the cell and how the association and dissociation of the purinosome was regulated. By probing for protein-protein interactions within the purinosome, we can detect the proximity of the various biosynthetic enzymes in the pathway. While their proximity could also result from encapsulation by a scaffolding protein, sheltered by the microtubules, it was important to establish which were in actual physical contact given the transient nature of the complex. This TANGO method, as an alternative to fluorescence imaging, provided us with a probe with different sensitivity. Consequently, we were also able to document the lower level of purinosome formation under the purine-rich growth condition, which was difficult to visualize with fluorescence imaging. Moreover, the detection of purinosomes in purine-rich medium supports the hypothesis that the pathway enzymes generally function through this transient complex.
In this study, we used a genetically encoded assay to probe for PPIs amongst the purinosome proteins. We created prey proteins from a TEV protease-purinosome enzyme fusion and bait proteins from a tTA transcription-factorpurinosome enzyme fusion. Release of tTA led to expression of luciferase and a luminescence signal. Diffusive TEV only induced marginal cleavage of its substrate, as measured by luciferase activity. By tagging TEV and its substrate to the same de novo purine biosynthetic enzymes, which are known to form oligomers in cells, we observed the expected signals (Figure 1 ) and verify the method. The increase in the luciferase signal in the case of hFGAMS, which is proposed to be a monomer in cells, suggests that other copies of this protein became juxtaposed by interacting with other cellular purinosome enzymes within a large protein complex.
When probing the proximity between different proteins in the pathway, we noticed not only the strong signal increases induced by the interactions of hFGAMS and hPPAT with other pathway proteins (with the exception of hTrifGART) but also strikingly similar patterns (Figure 2A and 2C) . We interpret these data in terms of a hPPAT-hFGAMS complex. Although the protein pairs hTrifGART-hFGAMS and hTrifGART-hPPAT did not induce a large increase in signal, the test with individual hTrifGART domains indicated PPIs between hTrifGART/hFGAMS and hPPAT, thus expanding the complex to include hTrifGART. Again, the pattern ( Figure 3B, 3C ) was nearly identical. From these collective data the first three enzymes in the pathway, hPPAT, hTrifGART and hFGAMS, appear to form a core for the purinosome.
In testing the relationship of hPAICS, hASL and hATIC with other proteins in the pathway, we saw different patterns depending on whether they acted as bait/prey proteins. As prey against hPPAT, hTrifGART and hFGAMS, all three gave strong similar patterns ( Figure 2) . As bait proteins, all three showed a similar pattern of low signal strength (Figure 4 ) against these three proteins.
This behavior fits with hPPAT, hTrifGART, and hFGAMS acting as a threeenzyme core complex. Against each other, i.e., one as prey, the other as bait or vice versa, reciprocal patterns were not retained (Figure 4 ). This finding may be rationalized by proposing that the three enzymes act individually to generate very transient short-lived complexes relative to the time scale required for TEV protease cleavage of the linker ( Figure 4A , B, and C).
Our results of the investigation of proteinprotein interactions within the purinosome are consistent with our previous finding of purinosome protein colocalization using fluorescence microscopy. The method employed herein provided insights as to whether the proteins actually contact one another. The data showed that all six enzymes in the pathway are in contact for a sufficient period to be captured by the Tango Assay. Moreover there is evidence of a core complex of the first three enzymes in the pathway: hPPAT, hTrifGART, and hFGAMS, that has interactions with the remaining enzymes: hPAICS, hASL, and hATIC but also the latter interact individually with each other ( Figure 5 ). This intriguing conclusion will be tested by other methods. tTA diffuses into the nucleus, binds to its specific inducible promoter and induces the expression of firefly luciferase, which is then detected in a luciferase assay. (C) The luciferase reporter assay using individual enzymes as both bait and prey proteins. The x-axis defines the proteins used as bait. TEV expressed without a fusion protein was used as control. Each set of experiments was tested with HeLa cells cultured under both purine-rich and purine-depleted conditions. The firefly luciferase activity (RLU) was measured and normalized to the renilla luciferase activity as described in materials and methods.
Note: htGART=hTrifGART. forms, which consisted of only two domains from the N-or C-terminus of hTrifGART, were also used as prey proteins to test their interaction with other purine biosynthetic enzymes. (B) Luciferase reporter assay using hFGAMS as the bait protein and the different forms or subdomains of hTrifGART, as described in Figure 3A , as prey proteins (defined on x-axis). (C) Luciferase reporter assay using hPPAT as the bait protein and different forms or subdomains of hTrifGART, as described in Figure 3A , as prey proteins (defined on x-axis). Note: N-or C-term are the N-or C-terminus of hTrfGART. by guest on October 2, 2017 
